OIP5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.635360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.216600E-01
Normal-vs-Stage2
1.376210E-01
Normal-vs-Stage3
3.411200E-01
Normal-vs-Stage4
2.701400E-01
Stage1-vs-Stage2
5.660200E-01
Stage1-vs-Stage3
6.821200E-01
Stage1-vs-Stage4
9.161000E-01
Stage2-vs-Stage3
3.528200E-01
Stage2-vs-Stage4
5.515600E-01
Stage3-vs-Stage4
7.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.587010E-01
Normal-vs-AfricanAmerican
4.945200E-01
Normal-vs-Asian
7.450000E-02
Caucasian-vs-AfricanAmerican
5.101000E-01
Caucasian-vs-Asian
7.420200E-01
AfricanAmerican-vs-Asian
4.497200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.794150E-01
Normal-vs-Female
1.549420E-01
Male-vs-Female
4.185200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.587000E-01
Normal-vs-Age(41-60Yrs)
1.748600E-01
Normal-vs-Age(61-80Yrs)
1.696220E-01
Normal-vs-Age(81-100Yrs)
8.146000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.208200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.886000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.897400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.711000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.519400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.743600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.596360E-01
Normal-vs-Daily Drinker
1.517600E-01
Normal-vs-Weekly Drinker
2.325600E-01
Normal-vs-Occasional Drinker
1.404600E-01
Normal-vs-Social Drinker
2.067600E-01
Non Drinker-vs-Daily Drinker
8.067200E-01
Non Drinker-vs-Weekly Drinker
7.981800E-01
Non Drinker-vs-Occasional Drinker
7.085000E-01
Non Drinker-vs-Social Drinker
3.592800E-01
Daily Drinker-vs-Weekly Drinker
6.650400E-01
Daily Drinker-vs-Occasional Drinker
5.627400E-01
Daily Drinker-vs-Social Drinker
2.824200E-01
Weekly Drinker-vs-Occasional Drinker
9.493200E-01
Weekly Drinker-vs-Social Drinker
5.765800E-01
Occasional Drinker-vs-Social Drinker
5.464600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.397000E-01
Normal-vs-Grade 2
7.960800E-01
Normal-vs-Grade 3
6.111400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.884540E-03
Grade 1-vs-Grade 3
1.142020E-03
Grade 1-vs-Grade 4
6.397000E-01
Grade 2-vs-Grade 3
3.823200E-01
Grade 2-vs-Grade 4
7.960800E-01
Grade 3-vs-Grade 4
6.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.021600E-01
Normal-vs-NonDiabetic
1.225850E-01
Diabetic-vs-NonDiabetic
1.568590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.262100E-02
Normal-vs-NoPancreatitis
1.800440E-01
Pancreatitis-vs-NoPancreatitis
3.612100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.448630E-01
Normal-vs-N1
1.513760E-01
N0-vs-N1
3.368200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.243530E-02
Normal-vs-TP53-NonMutant
2.700600E-01
TP53-Mutant-vs-TP53-NonMutant
5.37199951189393E-10
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
